扫除旧的蓝图:是否是时候重新考虑用于治疗药物开发的甲基酸盐受体2吗?
Anton Bespalov1, Robert Lütjens2, Dario Doller3
1EXCIVA, Heidelberg, Germany.
Pharmacology, biochemistry, and behavior
|November 21, 2024
概括
甲基酸盐受体2 (mGlu2) 的甲基酸盐受体2 (mGlu2) 激动剂在精神分裂症等神经精神障碍方面显示出有前途. 未来的研究应该专注于新的假设和识别治疗响应者,以提高临床成功.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 甲基酸盐受体2 (mGlu2) 是神经精神病学中一个关键的治疗点.
- 在精神分裂症中使用mGlu2/3受体激动剂的先前临床试验产生了混合的结果.
- 预计对神经精神疾病的mGlu2受体调节有新的兴趣.
研究的目的:
- 审查针对精神分裂症mGlu2/3受体的临床试验的理由和结果.
- 总结从过去的mGlu研究项目中学到的经验教训.
- 建议未来的研究方向,以优化基于mGlu2受体的疗法.
主要方法:
- 对mGlu2/3受体激动剂的临床试验数据和临床前证据的审查.
- 对前期治疗方案的成功或失败有助于因素的分析.
- 识别临床前研究有效性和生物标志物开发方面的知识差距.
主要成果:
- 有选择性,具有透中枢神经系统 (CNS) 的强效药物可用于假设测试.
- 之前的节目强调需要考虑orthosteric和allosteric调制策略.
- 花计划的停止强调了识别治疗响应者的挑战.
结论:
- 未来的研究应该扩展到超出预突触mGlu2受体刺激的范围,并以科学为导向.
- 提高临床前研究的内部有效性对于重新启动研究工作至关重要.
- 开发响应预测生物标志物和定义响应群体对于推进mGlu2向疗法的发展至关重要.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
Antiepileptic Drugs: Glutamate Antagonists
283
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
283
Ligand-gated Ion Channels
12.2K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
251
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
251


